Health
FDA Approves Moderna's mRNA Flu Vaccine, a First
The FDA has approved Moderna's mFLUSIVA, the first mRNA-based flu vaccine, for adults 50 and older. The approval marks a milestone in vaccine technology.
—5 min read
Tag
3 articles
The FDA has approved Moderna's mFLUSIVA, the first mRNA-based flu vaccine, for adults 50 and older. The approval marks a milestone in vaccine technology.
The FDA faces an Aug. 5 decision on Moderna's mRNA flu shot — a first for the U.S. and a test of vaccine policy under HHS Secretary RFK Jr.'s skepticism.
An FDA advisory committee voted 9-0 to recommend Moderna's mRNA flu vaccine, marking the panel's first new vaccine endorsement in over three years.